Back to results
US 2026/0242349 A1Published application
N,n'-sulfonimidamides as anticancer, antiinflammatory, antifibrotic and neuroprotective agents
AssigneeAtux Iskay LLC
InventorMichael Ohlmeyer
Life of this patent
Estimating the term…
Abstract
A genus of N,N′-sulfonimidamides is disclosed. The compounds are of the following genus: Formula (i) or a pharmaceutically acceptable salt thereof. The compounds are useful in the treatment of a variety of disorders, including as a monotherapy in cancer treatment, or used in combination with other drugs to restore sensitivity to chemotherapy where resistance has developed.
Claims20
A compound of formula I:
- or a pharmaceutically acceptable salt thereof,
- wherein:
- A is N or CH
- B is absent or is selected from a direct bond, —CH2CH2—, —CH═CH—, O, S, or —NRB—C(O)—;
- R1 is selected from CH2 and may also be —O— or NRQ when A is CH only;
- R2 is selected from CH2 or R1 and R2 taken together may for a carbon-carbon double bond;
- Rim is selected from H or lower alkyl
- U, V and W are independently cabocyclic aromatic or heteroaromatic rings;
- n=0 or 1;
- X1, X2, X3 and X4 are independently selected in each instance from hydrogen, halogen, nitro, cyano, (C1-C6)alkyl optionally substituted with —OH, (C1-C6)haloalkyl, (C1-C6)haloalkoxy, (C1-C6)haloalkylthio, —NR3R4, —OR3, —C(O)R3, —OC(O)R3, —C(O)NR3R4, —C(O)OR3, —SR3, —SO2R3, and —SO2NR3R4;
- Z1 and Z2 are independently selected in each instance from hydrogen, halogen, nitro, cyano, azido, (C1-C6)alkyl, (C1-C6)haloalkyl, (C1-C6)haloalkoxy, (C1-C6)haloalkylthio, —NR3R4, —NR3C(O)R4, —NR3C(O)OR5, —OR3, —C(O)R3, —OC(O)R3, —C(O)NR3R4, —C(O)OR3, —SR3, —SO2R3, —SO2NR3R4, and five membered heterocyclyl;
- RB is selected from H, or lower alkyl
- RQ is selected from H, optionally substituted lower alkyl, aryl
- R3, R4 and R5 are lower alkyl.
11 more elements
Dependencies are inferred from the claim text.